Stock PTIX PROTAGENIC THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Protagenic Therapeutics, Inc.

Equities

PTIX

US74365N2027

Market Closed - Nasdaq
Other stock markets
 16:30:00 2024-05-14 EDT 		5-day change 1st Jan Change
1.25 USD -7.08% Intraday chart for Protagenic Therapeutics, Inc. +2.46% +26.26%
05-01 Protagenic Therapeutics, Inc. Completes Enrollment in Single Dose Portion of Phase 1 of Innovative Stress Disorder Trial CI
04-01 Protagenic Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Protagenic Therapeutics, Inc.
AQ
Protagenic Therapeutics Achieves First Clinical Safety Milestone with its Novel Neuropeptide for the Potential Treatment of Stress-Related Disorders
AQ
PROTAGENIC THERAPEUTICS, INC.NEW Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
AQ
PROTAGENIC THERAPEUTICS, INC.NEW : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
PROTAGENIC THERAPEUTICS, INC.NEW : Submission of Matters to a Vote of Security Holders, Other Events (form 8-K)
AQ
PROTAGENIC THERAPEUTICS, INC.NEW Management's Discussion and Analysis of Financial Condition and Results of Operation (form 10-Q)
AQ
PROTAGENIC THERAPEUTICS, INC.NEW : Other Events (form 8-K)
AQ
PROTAGENIC THERAPEUTICS, INC.NEW Management's Discussion and Analysis of Financial Condition and Results of Operation (form 10-Q)
AQ
PROTAGENIC THERAPEUTICS, INC.NEW : Other Events (form 8-K)
AQ
PROTAGENIC THERAPEUTICS, INC.NEW Management's Discussion and Analysis of Financial Condition and Results of Operation (form 10-Q)
AQ
Protagenic Therapeutics : to Present at the B. Riley Securities Neuro and Ophthalmology Virtual Investor Conference on April 27th
PU
PROTAGENIC THERAPEUTICS, INC.NEW Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
AQ
Protagenic Therapeutics Announces Third Quarter 2021 Results and Business Update
AQ
PROTAGENIC THERAPEUTICS, INC.NEW Management's Discussion and Analysis of Financial Condition and Results of Operation (form 10-Q)
AQ
PROTAGENIC THERAPEUTICS, INC.NEW : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)
AQ
Protagenic Therapeutics : Amended and Restated Certificate of Incorporation (Form 8-K)
PU
PROTAGENIC THERAPEUTICS, INC.NEW : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)
AQ
Protagenic Therapeutics : to Host Virtual Science Review Wednesday, September 8th at 10 AM ET
AQ
Protagenic Therapeutics : Announces Second Quarter 2021 Results and (Form 8-K)
PU
PROTAGENIC THERAPEUTICS, INC.NEW : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PTIX Stock
  4. News Protagenic Therapeutics, Inc.
  5. Press Releases
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW